Aethlon Medical, Inc. announced the pricing of a public offering of 5,000,000 shares of its common stock and warrants.
The public offering price is set at $0.90 per share, with accompanying warrants.
The gross proceeds from the offering are expected to be approximately $4.5 million.
Public Offering Details
5,000,000 shares of common stock and warrants priced at $0.90 per share.
Use of Proceeds
Intends to utilize net proceeds for general corporate purposes, including clinical trial expenses and research.
Exclusive Placement Agent
Maxim Group LLC is serving as the exclusive placement agent for the offering.
- The offering aims to raise funds for Aethlon's ongoing operations and development initiatives.
- The pricing of the shares and warrants provides insights into investor demand for the company's offerings.
Aethlon Medical's successful pricing of the public offering indicates market confidence and provides funding for future growth and development initiatives.